BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15870526)

  • 21. How predictive is a cervical smear suggesting glandular neoplasia?
    Mathers ME; Johnson SJ; Wadehra V
    Cytopathology; 2002 Apr; 13(2):83-91. PubMed ID: 11952746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears.
    Novotny DB; Maygarden SJ; Johnson DE; Frable WJ
    Acta Cytol; 1992; 36(1):1-10. PubMed ID: 1546503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the cytologic examination for the diagnosis of endocervical adenocarcinoma in situ: cytologic-histologic correlation in 60 cases.
    Zardo LM; Thuler LC; Zeferino LC; Horta NM; Fonseca Rde C
    Acta Cytol; 2009; 53(5):558-64. PubMed ID: 19798884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin.
    Simsir A; Hwang S; Cangiarella J; Elgert P; Levine P; Sheffield MV; Roberson J; Talley L; Chhieng DC
    Cancer; 2003 Dec; 99(6):323-30. PubMed ID: 14681938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytologic features of high-grade squamous intraepithelial lesions involving endocervical glands on ThinPrep cytology.
    Selvaggi SM
    Diagn Cytopathol; 2002 Mar; 26(3):181-5. PubMed ID: 11892025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity and specificity of the Pap smear for glandular lesions of the cervix and endometrium.
    Geldenhuys L; Murray ML
    Acta Cytol; 2007; 51(1):47-50. PubMed ID: 17328495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glandular lesions of the cervix on thin-layer Pap tests. Validity of cytologic criteria used in identifying significant lesions.
    Ozkan F; Ramzy I; Mody DR
    Acta Cytol; 2004; 48(3):372-9. PubMed ID: 15192953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of atypical glandular cells of uncertain significance in cervical cytologic smears.
    Korn AP; Judson PL; Zaloudek CJ
    J Reprod Med; 1998 Sep; 43(9):774-8. PubMed ID: 9777615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
    Ullal A; Roberts M; Bulmer JN; Mathers ME; Wadehra V
    Cytopathology; 2009 Dec; 20(6):359-66. PubMed ID: 18557985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of atypical glandular cells in cervical-endocervical smears.
    Schindler S; Pooley RJ; De Frias DV; Yu GH; Bedrossian CW
    Ann Diagn Pathol; 1998 Oct; 2(5):312-7. PubMed ID: 9845755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases.
    Lee KR; Minter LJ; Granter SR
    Am J Clin Pathol; 1997 Jan; 107(1):30-5. PubMed ID: 8980364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reliability of a cytological prediction of cervical adenocarcinoma in situ.
    Laverty CR; Farnsworth A; Thurloe J; Bowditch R
    Aust N Z J Obstet Gynaecol; 1988 Nov; 28(4):307-12. PubMed ID: 3250449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases.
    Qizilbash AH
    Am J Clin Pathol; 1975 Aug; 64(2):155-70. PubMed ID: 1155380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri.
    Krumins I; Young Q; Pacey F; Bousfield L; Mulhearn L
    Acta Cytol; 1977; 21(2):320-9. PubMed ID: 266347
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of endocervical canal topography, tubal metaplasia, and high canal sampling on the cytologic presentation of nonneoplastic endocervical cells.
    Babkowski RC; Wilbur DC; Rutkowski MA; Facik MS; Bonfiglio TA
    Am J Clin Pathol; 1996 Apr; 105(4):403-10. PubMed ID: 8604682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytologic, histologic and cytophometric findings in an adenocarcinoma in situ of the uterine cervix].
    Sachs H; Würthner K
    Geburtshilfe Frauenheilkd; 1972 Oct; 32(10):846-9. PubMed ID: 4652280
    [No Abstract]   [Full Text] [Related]  

  • 39. Endocervical atypical glandular cells of undetermined significance. I. Morphometric and cytologic characterization of cases that "cannot rule out adenocarcinoma in situ".
    Cenci M; Mancini R; Nofroni I; Vecchione A
    Acta Cytol; 2000; 44(3):319-26. PubMed ID: 10833985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening.
    Kennedy AW; Salmieri SS; Wirth SL; Biscotti CV; Tuason LJ; Travarca MJ
    Gynecol Oncol; 1996 Oct; 63(1):14-8. PubMed ID: 8898161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.